Arab Finance: Minapharm Pharmaceuticals (Minapharm) posted a 70.6% year-on-year (YoY) drop in standalone profit after tax during the first nine months of 2023 to EGP 62.869 million, compared to EGP 214.094 million, according to financial statement filed to the Egyptian Exchange (EGX) on November 15^th.

Standalone net sales rose to EGP 1.883 billion during the January-September period from EGP 1.698 billion during the first nine months of 2022.

Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It distributes its products within and outside Egypt.

Arab Cotton Ginning sees 20% YoY drop in FY2024/25 consolidated profits Updated 12/2/2025 10:45:00 AM

Cairo Housing's consolidated profits drop 94.3% YoY in 9 months Updated 12/2/2025 9:44:00 AM

Integrated Engineering logs EGP 2.33M consolidated profits in 9 months Updated 12/1/2025 12:54:00 PM

ERC logs EGP 102.8M in consolidated profits over 9 months Updated 12/1/2025 11:58:00 AM

FABMISR posts 8% YoY jump in net profit over 9 months Updated 11/30/2025 3:33:00 PM